Skip to content
Companies

Cellular Logistics

Biomaterial that helps heal heart tissue after heart attack

Raised to date

$100K

of $450K offered across 2 Form D filings

Still open
$350K
Investors
2
Last filed
Jul 15, 2026

About

Cellular Logistics, Inc. is a biotechnology company operating out of Madison, Wisconsin, focused on pioneering advanced regenerative therapies for patients with various cardiovascular diseases. They aim to repair damaged heart tissue and prevent heart failure, particularly in post-heart attack patients, addressing a critical need in cardiac care.

Advanced acellular biomaterial for heart regeneration

Funding

$350K round, first sold Mar 2025$50K sold$300K still openMar 20252026
Now
  • DebtFiled Jul 15, 2026Form D
    $50K/ $100K
  • DebtFiled Apr 11, 2025Form D
    $50K/ $350K

Product

CFX™

Biomaterial Therapy

CFX™ is a cutting-edge acellular biomaterial engineered to support heart healing and curb heart failure progression. This technology activates the body's inherent repair mechanisms within damaged heart tissue, induces the development of new blood vessels, and mitigates detrimental inflammatory responses that often result in scarring. Its versatility allows to be used alone or in conjunction with other regenerative medicine approaches, boosting their effectiveness and retention in the heart.

  • Activates natural repair mechanisms
  • Stimulates new blood vessel formation
  • Reduces inflammatory responses

Built for

Cardiac Care Providers

People on file